A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease
Top Cited Papers
- 1 July 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 123 (1), 163-172
- https://doi.org/10.1053/gast.2002.34235
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Vibrio cholerae-Induced Cellular Responses of Polarized T84 Intestinal Epithelial Cells Are Dependent on Production of Cholera Toxin and the RTX ToxinInfection and Immunity, 2001
- Myosin II Light Chain Phosphorylation Regulates Membrane Localization and Apoptotic Signaling of Tumor Necrosis Factor Receptor-1Published by Elsevier ,2001
- Apically Exposed, Tight Junction-Associated β1-Integrins Allow Binding and YopE-Mediated Perturbation of Epithelial Barriers by Wild-Type Yersinia BacteriaInfection and Immunity, 2000
- Abnormal Intestinal Permeability Predicts Relapse in Inactive Crohn DiseaseScandinavian Journal of Gastroenterology, 2000
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisGastroenterology, 1999
- Abnormal intestinal permeability predicts relapse in patients with inactive Crohn's diseaseGastroenterology, 1998
- Tumour Necrosis factor-α induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayersCytokine, 1995
- Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.Journal of Clinical Investigation, 1989
- Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.Journal of Clinical Investigation, 1988